Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
No. 16, Xingguo Road, Xiuying District, Haikou, China
Overview
Founded in 2000, Hainan Shuangcheng Pharmaceutical Co., Ltd. is a high-tech enterprise featuring chemically synthesized polypeptide drugs. It was listed on the Shenzhen Stock Exchange (stock code 002693) in August 2012 and specializes in the research and development, production and sales of chemically synthesized polypeptide drugs. The company has formed a mature technical system in the synthesis, purification, analysis, quality assurance, activity determination and preparation process of polypeptides. It has successfully developed a number of chemically synthesized polypeptides such as thymosin for injection ("Kitai"), somatostatin for injection, bivalirudin for injection, and etibatin injection. Among them, the thymosin method has passed the consistency evaluation and has been approved by the Italian market, and bivalirudin and etibatin anda have been approved by the US FDA. The marketing network covers more than 30 provinces and cities in China, more than 600 pharmaceutical manufacturers, and more than 10,000 hospital terminals. The company is strategically positioned to become a major global supplier of peptide APIs and a major producer of peptide generic pharmaceutical formulations.
Notes
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is located at No. 16, Xingguo Road, Xiuying District, Haikou, China.
Website: https://www.shuangchengmed.com